Deep Diamond India Ltd

AGM Details

• Date and time: 30 September 2026, 11:30 A.M. IST.
• Mode: Video Conferencing or OAVM, deemed to be at the registered office.
• Record date for voting eligibility: 23 September 2026.
• Shareholders on record: 90,600 as of record date.

Voting and Scrutinizer

• Voting held via remote e-voting and AGM proceedings; scrutinizer report submitted.
• Cut-off date for voting: 23 September 2026.
• Total attendees via video conferencing: 51.
• Results published on BSE and NSDL websites.
• AGM concluded at 12:28 P.M. after 15 minutes for e-voting.
• Resolutions are listed in Annexure-1 attached.

Deep Health AI India Limited: Trading window closed from October 01, 2026 until 48 hours after the declaration of Un-Audited Financial Results for the Quarter ended September 30, 2026.

Resignation of NED

• Resignation of Rajesh Nandkishore Pherwani as Non-Executive Independent Director, effective Sep 11, 2026, due to personal pre-occupation.
• Directorship held in Kshitij Polyline Limited as Non-Executive Independent Director.
• Director confirms there are no other material reasons for resignation.

AGM and annual report details

• 32nd AGM on Sept 30, 2026 at 11:30 IST via VC/OAVM.
• Integrated Annual Report for FY 2025-26 will be accessible online with the AGM notice.
• E-voting window runs Sept 27, 2026 09:00 to Sept 29, 2026 17:00 IST; cut-off Sept 23, 2026.
• Notice and Integrated Annual Report accessible via company website, NSDL evoting site, and BSE attachment link.
• Physical copies of the Integrated Annual Report available on request by Sept 29, 2026.

Financial highlights

• Stand-alone total income: Rs 84,902,285; PAT: Rs 12,991,124; PBT: Rs 17,624,224; EPS: Rs 0.14.
• Revenue from operations: Rs 425,000; EBITDA: Rs (84,705,682) loss.
• Rights issue proceeds: Rs 39.97 crore; 9,61,00,000 shares issued.
• Name change to Deep Health AI India Limited on 9 February 2026.

Capital structure & liquidity

• Authorized share capital: Rs 50 crore; issued & paid-up capital: Rs 1441.50 lakh post-rights.
• Borrowings: Rs 37,281; Cash and cash equivalents: Rs 8,33,847.
• Interim dividend declared: Rs 1,35,26,210; no final dividend.
• All shares are in dematerialised form; RTA appointed for transfers.

Governance & management changes

• Mr. Narayan Singh Rathore appointed Managing Director w.e.f 18-01-2025; CFO Laveena Pokharna w.e.f 10-03-2025.
• Independent Directors changes: Shashi Kala Dhabriya (appointed 20-03-2026); Kailash Chandra ceased 03-04-2026.
• Virendra Choubisa appointed Non-Executive Independent Director 03-09-2026.
• Statutory auditor appointment: M/s Vimal C Surana & Co for 2026-2032.

Strategic developments & risks

• Oasis Ceramics acquisition under IBC; total consideration Rs 32 crore; partial payments and extension sought.
• Exceptional loss recognized: Rs 5.76 crore due to delays and potential liquidation.
• Rights issue proceeds deviation: Rs 37.47 crore invested in securities; ratified 22-01-2026.
• Divestment of Hemonc Pharma; strike-off of Microcure Biotech.

Audits & internal controls

• Secretarial audit: delay in submission of FY2024-25 Annual Report; fine of Rs 7,080.
• Statutory audits: current auditors VRSK & Co; new auditors M/s Vimal C Surana & Co appointed.
• Internal controls are adequate; no material weaknesses reported.

AGM notice & regulatory updates

• 32nd AGM via VC/OAVM on 30 Sept 2026; venue deemed at registered office.
• Notice on company website; NSDL e-voting available; remote e-voting 27-29 Sept 2026.
• Special items include auditor appointment, independent director appointment, and remuneration revision.

AGM Details

• Date/time: 30 September 2026 at 11:30 A.M. (IST); mode: VC/OAVM.
• Venue deemed at registered office for meeting purposes.
• Record date/cut-off: 23 September 2026; remote e-voting: 27–29 September 2026.

Key Resolutions

• Ordinary: Adopt standalone financial statements for year ended 31 March 2026.
• Ordinary: Adopt consolidated financial statements for year ended 31 March 2026.
• Ordinary: Re-appoint Narayan Singh Rathore as Managing Director (retiring by rotation).
• Ordinary: Appoint M/s Vimal C Surana & Co. as Statutory Auditor for five consecutive years.
• Special: Appoint Virendra Choubisa as Non-Executive Independent Director for five years.
• Special: Revise remuneration of Narayan Singh Rathore to up to Rs 16.8 lakh per annum.

Voting Results

• Voting results not disclosed in the filing.

Dividend

• No final dividend proposed or approved at the AGM.

Director Changes

• Virendra Choubisa appointed Additional Non-Executive Independent Director for five-year term.
• Shashi Kala Dhabriya appointed Additional Non-Executive Independent Director; approved 30 Jul 2026 EGM.
• Kailash Chandra ceased as Independent Director on 3 Apr 2026.
• Narendra Kumar Shrimali resigned as Non-Executive Director on 24 Nov 2025.
• Narayan Singh Rathore re-appointed as Managing Director (Ordinary resolution).

Auditor Appointments

• Statutory Auditor appointed: M/s Vimal C Surana & Co. for five years (2026–2031).
• Remuneration: Rs 1.80 lakh per annum plus taxes and out-of-pocket costs.

Material Related Party Transactions

• No material related party transactions approved; RPTs were in ordinary course and at arm's length.

Other Material Approvals

• Agenda also includes MD remuneration revision and independent director appointment; no ESOPs noted.

Appointment of Independent Director

• Mr. Virendra Choubisa appointed as Additional Non-Executive Independent Director, effective 03 Sep 2026; five-year term; subject to approvals.

New Statutory Auditor Appointment

• M/s Vimal C Surana & Co. (CA firm) appointed Statutory Auditor; five-year term; filling prior tenure completion.

Completion of Previous Auditor's Tenure

• M/s VRSK & Co. LLP completed five-year tenure as Statutory Auditor; tenure concluded at AGM 30 Sep 2026.